You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lung Cancer Non Small Cell

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Propranolol
  • Propranolol hydrochloride
  • +2 more
  • (no location specified)
Jul 31, 2023

NSCLC Trial in Suzhou (Envafolimab Injection)

Recruiting
  • NSCLC
  • Envafolimab Injection
  • Suzhou, Jiangsu, China
    Northern Jiangsu People's Hospital
Oct 29, 2023

Lung Cancer Trial (exercise)

Not yet recruiting
  • Lung Cancer
  • exercise
  • (no location specified)
Jul 17, 2023

Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • (no location specified)
May 8, 2023

Advanced NSCLC Trial in Jinan (almonertinib)

Recruiting
  • Advanced Non-small Cell Lung Cancer
  • Jinan, Shandong, China
    Degan Lu
Sep 12, 2023

NSCLC Trial in Guangzhou (PLB1001)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Aug 15, 2023

Non-small Cell Lung Cancer With Central Nervous System

Recruiting
  • Lung Cancer With Central Nervous System Metastasis
  • lung cancer with brain /leptomeningeal metastasis
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 4, 2023

NSCLC Trial in Shanghai (BL-M02D1)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

NSCLC?EGFR Sensitive Mutation Trial in Bengbu, Changsha, Shanghai (MCLA-129: 1500mg or 2000mg IV Q2W, Befotertinib: 75 mg or 100

Not yet recruiting
  • Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
  • MCLA-129: 1500mg or 2000mg IV Q2W
  • Befotertinib: 75 mg or 100 mg Po QD
  • Bengbu, Anhui, China
  • +2 more
Aug 28, 2023

PET-CT Predicting Segement Specific Lymph Nodes Metastasis

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Shanghai, China
      Shanghai Cancer Center
    Jul 23, 2023

    NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

    Not yet recruiting
    • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
    • tereotactic body radiotherapy
    • (no location specified)
    Dec 1, 2023

    Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

    Not yet recruiting
    • NSCLC
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Aug 6, 2023

      NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Crizotinib - Usual
      • Crizotinib - Study
      • Rockville, Maryland
        Medicine Invention Design, Inc. - IORG0007849
      Aug 15, 2023

      NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

      Recruiting
      • Non-small Cell Lung Cancer
      • SH-1028 tablets
      • Placebo SH-1028 tablets
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Oct 6, 2023

      Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy Trial in Wuhan (CTV omitted or delineated)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • CTV omitted or delineated
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Sep 1, 2023

      Huaier Granules in Postoperative Adjuvant Therapy for Non-small

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Huaier granule
      • Control
      • Shenyang, Liaoning, China
        Liaoning Cancer Hospital & Institute
      Oct 27, 2023

      NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Sugemalimab and Chemotherapy
      • Changsha, China
        Hunan Cancer Hospital
      Jul 7, 2023

      China With Non-Small-Cell Lung Cancer That is Unable to be

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
        • (no location specified)
        May 16, 2023

        Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)

        Not yet recruiting
        • Advanced Squamous Non-Small-Cell Lung Cancer
        • (no location specified)
        Jun 11, 2023

        Non Small Cell Lung Cancer Recurrent Trial (Toripalimab, Anlotinib and Chemotherapy)

        Not yet recruiting
        • Non Small Cell Lung Cancer Recurrent
        • Toripalimab, Anlotinib and Chemotherapy
        • (no location specified)
        Apr 24, 2023

        NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

        Not yet recruiting
        • Non-small Cell Lung Cancer (NSCLC)
        • MK-2870
        • +2 more
        • (no location specified)
        Oct 3, 2023

        Lung Cancer, Non-squamous, Non-small Cell Trial (zongertinib, pembrolizumab, cisplatin)

        Not yet recruiting
        • Lung Cancer, Non-squamous, Non-small Cell
        • (no location specified)
        Nov 22, 2023

        NSCLC Trial (JDQ443)

        Not yet recruiting
        • NSCLC
        • (no location specified)
        Feb 2, 2023

        Genetic and Epigenetic Factors on Clinical Response and Toxicity

        Recruiting
        • Non Small Cell Lung Cancer
        • +2 more
        • Cisplatin injection
        • Cairo, Egypt
          Ain Shams University
        Feb 16, 2023

        Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)

        Recruiting
        • Carcinoma, Non-small-Cell Lung
        • New York, New York
        • +1 more
        Nov 8, 2023